Adverum Biotechnologies, Inc. (ADVM)
4.36
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
Adverum Biotechnologies Research and Development Expense (TTM): 128.88M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| Pfizer Inc. | 10.13B |
| Recursion Pharmaceuticals, Inc. | 433.37M |
| Quantum-Si, Inc. | 58.38M |
| X4 Pharmaceuticals, Inc. | 75.34M |